NurOwn Stem Cell Therapy for ALS Opens Phase 3 Clinical Trial NurOwn therapy is an effort to stop neurodegeneration for ALS at its root. It uses a stem cell platform that involves harvesting mesenchymal stem cells (MSC) and was developed by BrainStorm Cell Therapeutics. A Phase III trial is now underway and will take place[...]

A recent study done by researchers at Oregon State University gives us insight into why certain cells in the nervous system are prone to death and decay. To do this, they took a look at proteins that are affecting the cells.  Proteins play a very important role in the life of a cell. One of[...]

Tim Green, a former NFL player, is fighting against ALS and is working tirelessly to find a cure. On 60 Minutes Tim and his son Troy Green, give us insight into Tim’s life and how he deals with ALS. Tim feels that his purpose is to be the best husband, father, lawyer, writer, and businessman[...]

A recent paper was written on Parkinson’s disease showing that two conditions – oxidative stress and proteinopathy –   may help find the cause of ALS and other neurodegenerative diseases. The paper shows that two possible culprits of ALS may, in fact, be working together to destroy neurons in ALS patients. Although it is still unclear[...]

The FDA recently granted the status of ‘orphan drug’ to APB-102, a potential gene therapy for familial ALS. Orphan drug status is given to terminal diseases that affect small numbers of patients.  John Reilly, Chief Executive Officer and co-founder of Apic Bio says they plan to open a clinical trial for APB-102. This trial will[...]

UC San Diego School of Medicine researchers have discovered that prolonged cellular stress, like exposure to toxins, triggers clumping of proteins that affect normal motor neuron function – the nerve cells that control your muscles and the ability to breathe. Published in in Neuron, the researchers noticed that the motor neurons of ALS patients have excessive buildup[...]

This #GivingTuesday is an opportunity to advance a cure by donating to leading edge ALS research. The ALS Crowd Research Initiative is a campaign to find and fund the most promising research for ALS patients who are not obtain their best outcomes with today’s therapies. 100% of your donation will be directed to research. Help[...]

By Heather Simonsen on KSL.com Seth Christensen’s computer tracks his eye movements so he can type like he used to, before ALS, commonly called Lou Gehrig’s disease, began stealing his abilities seven years ago. After an active life with four kids, the Christensen family’s youngest is just a baby. The diagnosis was devastating. “We had[...]

Michael Conti spent a year and a half preparing for the Race Across America.  He was riding to fulfill a childhood dream and to raise funds for ALS Crowd. Just outside of Alamosa, Colorado on June 17 his ride came to an abrupt end after a semi truck rear ended the cyclist’s support car.  Michael[...]

What does a map plotting patients with ALS look like? One such map shows that lakes with cyanobacteria, or blue-green algae, may be linked to  ALS. Dr. Elijah Stommel and Dr. Tracie Caller of the Dartmouth-Hitchcock Medical Center found that people living around a freshwater lake that has frequent blooms of cyanobacteria are up 25[...]